Iceland· IS-IS/1/22/025/01
Meropenem SUN
A meropenem product containing meropenemum inn tríhýdrat, registered in Iceland by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Meropenem is registered in 18 of 19 countries.
Countries holding a registration under ATC J01DH02 (meropenem), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Meropenem · ATC J01DH02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of meropenem costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Meropenem · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$99.79
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Meropenemum INN tríhýdrat
- Manufacturer
- Sun Pharmaceutical Industries Europe B.V.
- Country
- Iceland (IS)
- ATC code
- J01DH02
- ATC class
- Meropenem
- Defined daily dose
- 3 g, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean191696500 mg x10 hglISK 13652
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for meropenem.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Meropenem · interactions on record
25 records
- 4 severe
- 20 moderate
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Meropenem in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARCHIFARMedochemie Bohemia, spol. s r.o., Praha
- FinlandMerocarbAntibiotice SA
- SpainARCHIFAR 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGMedochemie Iberia S.A.
- BelgiumMeronem IV 500 mgPfizer
- SwedenMerocarb 500 mg Pulver till injektions-/infusionsvätska, lösningAntibiotice SA
- IrelandMeropenem 500 mg powder for solution for injection or infusionFresenius Kabi Deutschland GmbH
- PolandMeronemPfizer Europe MA EEIG
- NorwayMeropenem B. BraunB.Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Merinfec, Meropenem Aptapharma
- Belgium · Meronem Iv, Meropenem Bradex
- Bulgaria · Meropenem Kabi, Meropenem-Tchaikapharma
- Cyprus · Archifar, Meropenem Aptapharma
- Czechia · Archifar, Meronem
- Germany · Meropenem, Meropenem Acs Dobfar
- Denmark · Merocarb, Meropenem "thrive"
- Estonia · Agenor, Meropenem Bausch Health
- Spain · Archifar, Meropenem Aurovit
- Finland · Merocarb, Meropenem Aptapharma
- France · Meronem, Meropenem Acs Dobfar
- United Kingdom (Northern Ireland) · Meronem Iv, Meropenem
- Greece · Carbenem, Homepen
- Croatia · Archifar, Meropenem Aptapharma
- Hungary · Meropenem Aptapharma, Meropenem Bradex
- Ireland · Meronem I.V., Meropenem
- Italy · Luxomer, Meropenem Acs Dobfar
- Lithuania · Agenorem, Meropenem Kabi
- Luxembourg · Meronem Iv, Meropenem Bradex
- Latvia · Archifar, Meropenem Kabi
- Malta · Archifar, Mepenex
- Netherlands · Meropenem Aptapharma, Meropenem Bradex
- Norway · Merocarb, Meropenem Aptapharma
- Poland · Meronem, Meropenem Aptapharma
- Portugal · Meropenem Atral, Meropenem Aurovitas
- Romania · Archifar, Loditer
- Sweden · Merocarb, Meronem
- Slovenia · Archifar, Meropenem Actavis
- Slovakia · Archifar, Merocarb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef2fe384-8f38-47da-849b-6f155adee767 GET /v1/drugs/ef2fe384-8f38-47da-849b-6f155adee767?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfs-/innrennslisstofn, lausn",
"source": "lyfjastofnun",
"atc_raw": "J01DH02",
"marketed": true,
"strength": "500 mg",
"ma_number": "IS/1/22/025/01",
"substance": "Meropenemum INN tríhýdrat",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44622"
}See everything about meropenem.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.